Search results
Why Chip ETFs May Be Poised for a Comeback
Momentum investing could be ready for a rebound after one of its sharpest pullbacks on record, according to Morgan Stanley strategist Michael Wilson, per Bloomberg, as quoted on Yahoo Finance. While
Rigetti Expands Hybrid Quantum HPC Push With New NSF Project
Rigetti Computing RGTI announced that it is partnering with Hewlett Packard Enterprise ("HPE") and the Pittsburgh Supercomputing Center ("PSC") to build TangleLab, a hybrid quantum-classical
Is Werner Stock a Buy as Earnings Improve but Valuation Stays Rich?
Werner Enterprises WERN is showing clearer signs of an earnings recovery as pricing, asset utilization and FirstFleet savings strengthen its truckload operations. The improvement has helped rebuild
Pembina Pipeline Q2 Earnings Miss Estimates, Revenues Increase Y/Y
Pembina Pipeline Corporation PBA reported second-quarter 2026 earnings per share of 48 cents, which missed the Zacks Consensus Estimate of 49 cents. However, it increased from the year-ago quarter’s
Can Snap-on's Diesel Laptops Deal Accelerate Its Diagnostics Growth?
Snap-on Incorporated SNA completed the approximately $100 million acquisition of Diesel Laptops on June 8, 2026, adding heavy-duty truck and equipment diagnostics, repair information and digital
Is Snap-on Stock a Buy as Strong Margins Meet a Premium Valuation?
Snap-on Incorporated SNA pairs resilient operations and strong cash generation with a valuation near the top of its five-year range. Second-quarter sales and earnings advanced, while gross margin
INSP Raises 2026 Outlook as Reimbursement Headwinds Start to Ease
Inspire Medical Systems, Inc. INSP raised its 2026 outlook after second-quarter results exceeded expectations. Better cost control, a richer mix of Inspire V implants and stronger cash generation
Is INSP a Buy as Margins Improve but Reimbursement Risks Persist?
Inspire Medical Systems, Inc. INSP offers investors a difficult trade-off. Its underpenetrated obstructive sleep apnea market, improving margins and financial flexibility support the long-term case.
Sterling Raises 2026 Outlook as Backlog Tops $5.6 Billion After Q2
Sterling Infrastructure, Inc. STRL raised its 2026 outlook after second-quarter revenues increased 90% and adjusted earnings more than doubled. The update tests whether rapid expansion in
Is Sterling Stock a Buy as Growth Outruns Its Premium Valuation Today?
Sterling Infrastructure, Inc. STRL combines unusually rapid earnings expansion with a valuation that already assumes continued execution. The central question is whether mission-critical demand, a
Royalty Pharma Q2 Earnings Call Highlights
Key Points
- Interested in Royalty Pharma PLC? Here are five stocks we like better.
- Royalty Pharma raised its 2026 outlook for the second consecutive quarter, now forecasting portfolio receipts
LogicBio Therapeutics: ContextLogic Unveils $850M gChem Specialty Chemicals Acquisition
Key Points
- Interested in LogicBio Therapeutics, Inc.? Here are five stocks we like better.
- ContextLogic plans to acquire gChem for $850 million in cash, its second operating-business acquisition
The Cheapest ETFs for Building a Core Portfolio
Investors love ETFs because of their low cost, tax efficiency, and transparency. It is now possible to build an ultra-low-cost, diversified portfolio using just a few ETFs. Expenses matter,
Alto Ingredients Q2 Earnings Call Highlights
Key Points
- Interested in Alto Ingredients, Inc.? Here are five stocks we like better.
- Alto Ingredients reported its fourth consecutive quarter of profitability, with second-quarter net sales
DoorDash Q2 Earnings Call Highlights
Key Points
- Interested in DoorDash, Inc.? Here are five stocks we like better.
- Grocery and new verticals are gaining momentum: DoorDash said grocery is its fastest-growing marketplace segment
Coherus Oncology Q2 Earnings Call Highlights
Key Points
- Interested in Coherus Oncology, Inc.? Here are five stocks we like better.
- Clinical milestones are approaching: Coherus expects formal October data from its fully enrolled
Central Garden & Pet Q3 Earnings Call Highlights
Key Points
- Interested in Central Garden & Pet Company? Here are five stocks we like better.
- Central Garden & Pet raised its fiscal 2026 adjusted EPS outlook to $2.85 or better from $2.70
Carlsmed Q2 Earnings Call Highlights
Key Points
- Interested in Carlsmed, Inc.? Here are five stocks we like better.
- Carlsmed’s Q2 revenue rose 57% year over year to $18.9 million, driven by higher adoption of its aprevo lumbar
Evolus Q2 Earnings Call Highlights
Key Points
- Interested in Evolus, Inc.? Here are five stocks we like better.
- Strong second-quarter performance: Evolus reported 21% revenue growth to $84.1 million and its third consecutive